Indoco’s PAT jumps 62 per cent in Q4FY22
For the year ending March 22, the revenues grew by 23.4 per cent at Rs 1502.7 crores, as against Rs 1217.4 crores, same period…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Latest Updates
Valneva receives EUA from UAE for its inactivated COVID-19 vaccine
This authorisation follows conditional marketing authorisation from the UK MHRA, which was granted last month, and EUA from the…
Zydus Wellness’s revenue crosses Rs 2,000 crores in FY22
For the fourth quarter ended 31st March, 2022, the company reported consolidated income from operations of Rs 640 crores, up by…
Multiples private equity-led consortium invests Rs 6,850 million in BDR Pharma
The funds will be used by the company to build additional research and development capabilities in current and emerging areas,…
AbbVie and Cugene announce collaboration in autoimmune diseases
Under the terms of the agreement, Cugene will receive an upfront payment of $48.5 million, and will also be eligible to receive…
US FDA-Gujarat FDCA Regulatory Forum to be held from 17th to 19th May
In this meeting, 12 officials from the US FDA, senior officers from Gujarat FDCA and four drug officers nominated by Drugs…
FDA declines to authorise common antidepressant as COVID treatment
The generic drug belongs to an old, widely-used class of antidepressants called Selective Serotonin Reuptake Inhibitors (SSRIs)
Gerresheimer boosts global production capabilities with new facilities in India
By adding capacities in India, Gerresheimer intends to ensure consistent supply for critical pharma and healthcare facilities…
Takeda launches Adynovate to advance prophylaxis treatment for haemophilia patients in India
Adynovate, in combination with MYPKFIT, offers personalised treatment, and enables HCPs and patients to monitor factor levels from…
Biological E reduces Corbevax price to Rs 250 a dose
The decision comes within weeks of Biological E receiving the Emergency Use Authorisation (EUA) for children between five and 12…
Ayurveda industry set to enter cardiac department with scientific evidence
A four-day National Ayurveda Cardiology Symposium – first of its kind in India, was held to present and share various case studies…
SII seeks government nod to manufacture and stockpile qHPV vaccine against cervical cancer
The firm will soon seek market authorisation as well as a manufacturing licence from the Drugs Controller General of India (DCGI)…
Unable to sell Sputnik Light stock, Stelis Biopharma requests PM Modi for procurement of jabs
The Drugs Controller General of India (DCGI) had granted emergency use permission to Sputnik Light, subject to certain regulatory…
Switzerland authorises Moderna’s COVID vaccine for six-to-11-year olds
The approval is for the vaccine’s two-dose series of 50 micro gram per dose
Pfizer, EU push back COVID vaccine delivery to help booster campaign
The companies amended their supply agreement with the European Commission to push back delivery of doses scheduled for June…
ArisGlobal acquires Boehringer Ingelheim’s signal analytics technology
This digital innovation represents impactful progress industry-wide, as it opens an opportunity for many life sciences…
SII and Symbiosis International University sign MoU to set up research centre for vaccine and…
The MoU will see both the entities work towards promoting research and innovation to increase impact of vaccines, technologies and…
PM Modi seeks streamlining WHO’s vaccine approval process; calls for flexible rules by WTO
In his address at the second global COVID virtual summit, Modi, highlighting India’s role in combating the corona virus pandemic,…
Drug regulation in India: A roller coaster
Dr Shoibal Mukherjee, MD, DM Sr Consultant, Clinical Pharmacology and Drug Development, explains why the goal of making India a…
Myovant Sciences and Accord Healthcare enter into exclusive licence agreement to commercialise…
Myovant to receive an upfront payment of $50 million, is eligible to receive commercial launch, sales-based and other milestones…